342 related articles for article (PubMed ID: 12548507)
1. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
[TBL] [Abstract][Full Text] [Related]
2. Recombinant factor VIIa improves coagulopathy caused by liver failure.
Brown JB; Emerick KM; Brown DL; Whitington PF; Alonso EM
J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):268-72. PubMed ID: 12960648
[TBL] [Abstract][Full Text] [Related]
3. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases.
Pavese P; Bonadona A; Beaubien J; Labrecque P; Pernod G; Letoublon C; Barnoud D
Can J Anaesth; 2005 Jan; 52(1):26-9. PubMed ID: 15625252
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
Kwon JO; MacLaren R
Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
[TBL] [Abstract][Full Text] [Related]
5. The use of activated recombinant factor VII in a patient with fulminant hepatic failure requiring placement of an intracranial pressure monitor.
Meadows HB; Krisl JC; Greenberg CS; Mazur JE
Ann Pharmacother; 2011 Nov; 45(11):e60. PubMed ID: 22028416
[TBL] [Abstract][Full Text] [Related]
6. Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients. Report of three cases and review of the literature.
Morenski JD; Tobias JD; Jimenez DF
J Neurosurg; 2003 Mar; 98(3):611-6. PubMed ID: 12650436
[TBL] [Abstract][Full Text] [Related]
7. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma.
Stein DM; Dutton RP; Kramer ME; Scalea TM
J Trauma; 2009 Jan; 66(1):63-72; discussion 73-5. PubMed ID: 19131807
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
[TBL] [Abstract][Full Text] [Related]
9. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
10. Preemptive administration of recombinant factor VII (rVIIa) in patients transplanted due to fulminant Wilson's disease.
Czuprynska MM; Wawrzynowicz-Syczewska M; Jureczko L; Andrzejewska J; Jarosz K; Trzebicki J; Pacholczyk M; Chmura A; Wojcicki M
Ann Transplant; 2010; 15(3):7-10. PubMed ID: 20877260
[TBL] [Abstract][Full Text] [Related]
11. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy.
Gowers CJ; Parr MJ
Anaesth Intensive Care; 2005 Apr; 33(2):196-200. PubMed ID: 15960401
[TBL] [Abstract][Full Text] [Related]
12. Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy.
Atkison PR; Jardine L; Williams S; Barr RM; Quan D; Wall W
Transplant Proc; 2005 Mar; 37(2):1091-3. PubMed ID: 15848632
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of recombinant activated factor VII in patients with liver failure undergoing invasive procedures.
Krisl JC; Meadows HE; Greenberg CS; Mazur JE
Ann Pharmacother; 2011 Nov; 45(11):1433-8. PubMed ID: 22009992
[TBL] [Abstract][Full Text] [Related]
14. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
16. Insertion of intracranial pressure monitors in fulminant hepatic failure patients: early experience using recombinant factor VII.
Le TV; Rumbak MJ; Liu SS; Alsina AE; van Loveren H; Agazzi S
Neurosurgery; 2010 Mar; 66(3):455-8; discussion 458. PubMed ID: 20173540
[TBL] [Abstract][Full Text] [Related]
17. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients.
Park P; Fewel ME; Garton HJ; Thompson BG; Hoff JT
Neurosurgery; 2003 Jul; 53(1):34-8; discussion 38-9. PubMed ID: 12823871
[TBL] [Abstract][Full Text] [Related]
18. Acute coagulopathy after reperfusion of the liver graft in children correction with recombinant activated factor VII.
Markiewicz M; Kalicinski P; Kaminski A; Laniewski P; Ismail H; Drewniak T; Szymczak M; Nachulewicz P
Transplant Proc; 2003 Sep; 35(6):2318-9. PubMed ID: 14529927
[TBL] [Abstract][Full Text] [Related]
19. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.
McMullin NR; Kauvar DS; Currier HM; Baskin TW; Pusateri AE; Holcomb JB
Curr Surg; 2006; 63(4):246-51. PubMed ID: 16843774
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin complex concentrate: an effective therapy in reversing the coagulopathy of traumatic brain injury.
Joseph B; Hadjizacharia P; Aziz H; Kulvatunyou N; Tang A; Pandit V; Wynne J; O'Keeffe T; Friese RS; Rhee P
J Trauma Acute Care Surg; 2013 Jan; 74(1):248-53. PubMed ID: 23271101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
